Latest News in the pharma Industry

Market News

Accelerating freeze drying cycle development with just seven vials

Accelerating freeze drying cycle development with just seven vials

21 Jun 2017

Compared with other small-scale R&D freeze dryers, the LyoCapsule lyophilizer is the only system that can monitor and independently control the wall temperature via use of the center vial product temperature.

Read more 
Takeda completes new manufacturing facilities at the Oranienburg site in Germany

Takeda completes new manufacturing facilities at the Oranienburg site in Germany

20 Jun 2017

The manufacture of solid dosage form pharmaceutical products would be transferred from the Osaka Plant to the new plant.

Read more 
QuVa Pharma announces availability of sodium bicarbonate syringe

QuVa Pharma announces availability of sodium bicarbonate syringe

20 Jun 2017

Compounded Sodium Bicarbonate PF 8.4% 50mEq per syringe is expected to help alleviate chronic drug shortage impacting the nation's hospitals.

Read more 
Glenmark Pharmaceuticals licenses small molecule oncology compound from APC Therapeutics to expand IO portfolio

Glenmark Pharmaceuticals licenses small molecule oncology compound from APC Therapeutics to expand IO portfolio

20 Jun 2017

The compound has the potential to be used as a monotherapy or in combination with approved therapies to address unmet needs in cancer treatment.

Read more 
Merck Ventures creates new immuno-oncology company iOnctura

Merck Ventures creates new immuno-oncology company iOnctura

20 Jun 2017

iOnctura is set up to develop a pipeline of assets targeting immunosuppression in the tumour microenvironment.

Read more 
J&J completes acquisition of Actelion

J&J completes acquisition of Actelion

19 Jun 2017

Actelion will now become part of the Janssen Pharmaceutical Companies of J&J.

Read more 
Sandoz receives approval in Europe for Rixathon to treat blood cancers and immunological diseases

Sandoz receives approval in Europe for Rixathon to treat blood cancers and immunological diseases

19 Jun 2017

Sandoz now has four biosimilars approved in Europe - more than any other company.

Read more 
BMS to sell manufacturing facility in Swords, Ireland to SK Biotek

BMS to sell manufacturing facility in Swords, Ireland to SK Biotek

16 Jun 2017

Company shifts manufacturing focus in Ireland to reflect growing biologics portfolio with ongoing investment in Cruiserath biologics facility.

Read more 
FlyPharma Conference: Collaboration is the Key

FlyPharma Conference: "Collaboration is the Key"

16 Jun 2017

Delegates at the recent FlyPharma Conference pick out collaboration as their main goal for the coming year.

Read more 
Parexel and Sanofi collaborate to advance the use of wearable devices in life science industry

Parexel and Sanofi collaborate to advance the use of wearable devices in life science industry

15 Jun 2017

Preliminary findings from pilot study validate use of wearable technologies to collect data and manage clinical trials more effectively and efficiently.

Read more 
LifeArc, previously MRC Technology, set to transform the medical research landscape

LifeArc, previously MRC Technology, set to transform the medical research landscape

15 Jun 2017

Investment will focus on new innovations in therapeutics for neurodegeneration, antibiotic resistance, cancer and respiratory diseases.

Read more 
FDA accepts Sandoz regulatory submission for a generic version of Advair Diskus

FDA accepts Sandoz regulatory submission for a generic version of Advair Diskus

15 Jun 2017

Sandoz believes its combination product will offer asthma and COPD patients same safety and efficacy as reference medicine.

Read more